Y. Zhang | SONG LABhttps://playful-bavarois-78840e.netlify.app/author/y.-zhang/Y. ZhangHugo Blox Builder (https://hugoblox.com)en-usSat, 01 Aug 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/media/logo_hu11652092127514912302.pngY. Zhanghttps://playful-bavarois-78840e.netlify.app/author/y.-zhang/Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistancehttps://playful-bavarois-78840e.netlify.app/publication/cysltr1-tumor-promoting-myelopoiesis/Sat, 01 Aug 2026 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/cysltr1-tumor-promoting-myelopoiesis/4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor responsehttps://playful-bavarois-78840e.netlify.app/publication/4-1bb-a2b-cd8-tumor-response/Mon, 02 Jun 2025 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/4-1bb-a2b-cd8-tumor-response/Cancer-testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cellshttps://playful-bavarois-78840e.netlify.app/publication/magec2-taf9-cancer-cells/Fri, 01 Dec 2017 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-taf9-cancer-cells/Extracellular matrix protein Reelin promotes myeloma progression by facilitating tumor cell proliferation and glycolysishttps://playful-bavarois-78840e.netlify.app/publication/reelin-myeloma-progression/Wed, 01 Mar 2017 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/reelin-myeloma-progression/The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signalinghttps://playful-bavarois-78840e.netlify.app/publication/magec2-stat3-amoeboid-invasion/Wed, 01 Mar 2017 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-stat3-amoeboid-invasion/Thymic DCs derived IL-27 regulates the final maturation of CD4+ SP thymocyteshttps://playful-bavarois-78840e.netlify.app/publication/thymic-dc-il27-cd4-maturation/Fri, 29 Jul 2016 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/thymic-dc-il27-cd4-maturation/MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2https://playful-bavarois-78840e.netlify.app/publication/mir874-magec2-tumor-suppressor/Tue, 01 Mar 2016 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/mir874-magec2-tumor-suppressor/Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinomahttps://playful-bavarois-78840e.netlify.app/publication/kif23-hepatocellular-carcinoma/Wed, 16 Dec 2015 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/kif23-hepatocellular-carcinoma/Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin Ehttps://playful-bavarois-78840e.netlify.app/publication/magec2-rbx1-cyclin-e/Tue, 01 Dec 2015 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-rbx1-cyclin-e/Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulationhttps://playful-bavarois-78840e.netlify.app/publication/id1-treg-differentiation-tcr-costimulation/Tue, 15 Jul 2014 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/id1-treg-differentiation-tcr-costimulation/Id1 expression promotes peripheral CD4+ T cell proliferation and survival upon TCR activation without co-stimulationhttps://playful-bavarois-78840e.netlify.app/publication/id1-peripheral-cd4-tcell-survival/Sat, 15 Jun 2013 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/id1-peripheral-cd4-tcell-survival/Homeostatic Properties and Phenotypic Maturation of Murine CD4+ Pre-Thymic Emigrants in the Thymushttps://playful-bavarois-78840e.netlify.app/publication/cd4-prethymic-emigrants-thymus/Wed, 06 Feb 2013 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/cd4-prethymic-emigrants-thymus/Cancer-testis antigen HCA587-derived long peptide vaccine generates potent immunologic responses and antitumor effects in mouse modelhttps://playful-bavarois-78840e.netlify.app/publication/magec2-long-peptide-vaccine/Tue, 01 Jan 2013 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/magec2-long-peptide-vaccine/Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunityhttps://playful-bavarois-78840e.netlify.app/publication/curcumin-ctl-antitumor-immunity/Fri, 01 Apr 2011 00:00:00 +0000https://playful-bavarois-78840e.netlify.app/publication/curcumin-ctl-antitumor-immunity/